GlassScriptPhysician profile
Khalid Mehmood
NPI 1265606966
$1,500.47
in general payments reported to CMS, 2019-2025
18 companies · $269 in 2025
The $269 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $836 · 2020: $362 · 2021: $19.04 · 2022: $14.10 · 2025: $269.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $269.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $269.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mylan Specialty L.P. | $315.38 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $161.73 | 2019-2020 | |
| Stryker Corporation | $154.98 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| E.R. Squibb & Sons, L.L.C. | $136.71 | 2019-2020 | |
| Pfizer INC. | $125.35 | 2019-2020 | |
| Lilly USA, LLC | $114.20 | 2025 | Zepbound |
| Allergan, INC. | $94.17 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $85.19 | 2019-2020 | |
| Amgen INC. | $58.38 | 2019 | |
| Sanofi-Aventis U.S. LLC | $54.87 | 2019-2020 | |
| Ucb, INC. | $50.48 | 2019 | |
| Biomerieux INC | $34.78 | 2019 | |
| Amarin Pharma, INC. | $28.52 | 2020 | |
| Astellas Pharma US INC | $28.45 | 2019 | |
| Resmed Corp | $18.10 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pharming Healthcare, INC. | $14.10 | 2022 | |
| Insmed, INC. | $14.00 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $11.08 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Khalid Mehmood listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.